The End the Vaccine Carveout Act would expose vaccine makers to lawsuits that once drove companies out of the industry.
European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...
In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for ...
About four years after the case was filed—and against the backdrop of a significantly changed COVID-19 vaccine ...
A Single Shot to Shield Against Two Viruses: EMA Poised to Approve Moderna’s COVID-Flu Combo Vaccine
EMA backs Moderna’s dual COVID-19 and flu vaccine, mCombriax, paving the way for EU approval ahead of the 2026–2027 season.
Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
Fact check - There is no link between the discovery of cancer treatments and vaccines and the US leaving the WHO.
In a highly unusual move for a normally buttoned-up regulatory agency, a senior official with the US Food and Drug ...
In this week’s edition of InnovationRx, we look at the startup that wants to treat Alzheimer’s with microrobots, medical ...
According to Budiman, more than 125 countries have included the HPV vaccine in their national immunization programs. Research ...
Vietnam has launched clinical trials of a new antiviral drug that could offer fresh hope in the fight against dengue fever, a ...
Former assistant professor of epidemiology, immunology, and infectious disease at the Harvard T.H. Chan School of Public Health and pathology at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results